Needham Begins Coverage of ODDITY Tech with Buy Rating and Sets Price Target at $72
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 28 2025
0mins
Should l Buy ODD?
Source: Benzinga
Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.
Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters.
Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, sharing strategies and intelligence.
Market Winning Tool: Traders utilize Benzinga Pro's resources to enhance their trading success in the stock market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ODD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ODD
Wall Street analysts forecast ODD stock price to rise
8 Analyst Rating
6 Buy
2 Hold
0 Sell
Strong Buy
Current: 27.610
Low
49.00
Averages
66.63
High
80.00
Current: 27.610
Low
49.00
Averages
66.63
High
80.00
About ODD
Oddity Tech Ltd is an Israel-based company engaged in the beauty and wellness sector on the molecular level. The Company is operating a tech platform under its own brand on the Internet, whose purpose is to support a portfolio of brands and services connected to the beauty and wellness market and to develop products customized to the wishes of the Company's clients. The Company is using algorithms and machine learning models to match a corresponding physical product. Advanced biological models and machine learning-based tools are used to find new molecules for beauty and wellness purposes. The Company is active in research and development in areas such as data science, machine learning, and computer vision to enhance its products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Evercore ISI Sees Strong Outlook for Oddity Tech
- Investment Recommendation: Evercore ISI has added Oddity Tech Ltd. (ODD) to its list of best SMID Core Idea stock picks for 2026, citing the company's strong fundamentals and high-retention subscription model that demonstrates consistent cash generation capabilities.
- Revenue Growth Potential: Analyst Mark Mahaney highlighted that approximately two-thirds of Oddity Tech's revenue comes from repeat customers, indicating a defensive growth profile, with core brands expected to continue delivering double-digit growth, supporting future revenue increases.
- Attractive Valuation: Oddity Tech currently trades at 7X EV/EBITDA and 15X P/E, which is considered attractive relative to peers, potentially drawing more investor interest.
- Market Performance: Despite Oddity Tech's shares being down 18.0% year-to-date, the strong brand momentum and an upcoming major product cycle provide a favorable risk-reward outlook for investors.
See More
Oversold Consumer Staples Stocks Present Investment Opportunities: ODD, ELAB, ZVIA
- Oversold Stock Overview: In the consumer staples sector, ODDITY Tech, PMGC Holdings, and Zevia have relative strength indices (RSI) below 30, at 25.3, 16.2, and 26 respectively, indicating these stocks are significantly undervalued and may present buying opportunities for investors.
- ODDITY Tech Rating Adjustment: Keybanc analyst maintained an Overweight rating on ODDITY Tech but lowered the price target from $70 to $50, reflecting market caution regarding its future performance, despite its stock price falling approximately 20% over the past month.
- PMGC Holdings Reverse Split: PMGC Holdings announced a 1-for-4 reverse split and invested in non-controlling shares of Nuclea Energy; however, its stock plummeted 73% over the past month, currently at a 52-week low of $3.54 with an RSI of 16.2.
- Zevia Stock Performance: Telsey Advisory Group analyst maintained an Outperform rating for Zevia with a price target of $6, even as its stock fell 33% over the past month to a 52-week low of $1.66, with an RSI of 26 indicating potential for a rebound.
See More
Mid-to-Low Cap Consumer Staples Stocks Earn A+ EPS Revision Ratings
- Analyst Rating Upgrades: As earnings season begins, low-to-mid cap consumer staples stocks like The Andersons (ANDE) and Beyond Meat (BYND) have received an A+ EPS revision rating from analysts, indicating growing confidence in their profitability outlook.
- Improved Earnings Expectations: Companies such as Freshpet (FRPT) and John B. Sanfilippo & Son (JBSS) have shown strong performance in recent earnings estimate upgrades, suggesting an improvement in their fundamentals.
- Increased Market Attention: Firms like Oddity Tech (ODD) and Reynolds Consumer Products (REYN) are attracting investor interest due to their strong earnings momentum, with positive analyst revisions likely to drive stock price increases.
- Industry Trend Analysis: Companies such as Turning Point Brands (TPB) and Village Farms International (VFF) are performing well in the current market environment, demonstrating resilience in the consumer staples sector amid structural challenges.
See More
Oddity Tech Launches Methodiq Platform, Expected to Attract Tens of Millions of Users
- Data-Driven Growth: Oddity Tech has enhanced customer loyalty through its direct-to-consumer platform by leveraging data analytics, resulting in higher repeat purchase rates and increased shareholder value.
- Launch of Methodiq Platform: In November 2025, Oddity launched the Methodiq telehealth platform aimed at providing personalized treatment solutions for tens of millions of Americans suffering from skin conditions, which is expected to significantly enhance the company's long-term growth potential.
- Product Diversification: Methodiq will offer over 100 personalized treatment plans utilizing AI-powered skin analysis and computer vision technology, catering to diverse user needs and further expanding market share.
- Strategic Investment Outlook: With the launch of Methodiq, Oddity Tech is poised to attract more consumers willing to pay premium prices for beauty products, unlocking substantial growth opportunities and driving future shareholder returns.
See More
Oddity Launches Methodiq Platform, Expanding into Dermatological Health Market
- Market Potential: Oddity's addressable market is vast, as the beauty and wellness industry largely operates on an old-economy model, while Oddity's tech-driven e-commerce approach shows strong growth potential.
- Customer Loyalty Boost: By leveraging user data, Oddity has rapidly increased customer loyalty with impressive repeat purchase rates, thereby enhancing the company's competitive edge and shareholder value.
- New Platform Launch: In November 2025, Oddity launched the Methodiq telehealth platform aimed at providing effective treatments for dermatological issues to tens of millions of Americans, which is expected to significantly enhance the company's long-term growth potential.
- Product Diversification: Methodiq will offer over 100 personalized treatment plans utilizing AI technology and proprietary ingredients from Oddity Labs, catering to diverse user needs and further expanding Oddity's market share.
See More
Oddity Tech Reports 57% Revenue Growth Post-IPO and Margin Expansion
- Significant Revenue Growth: Oddity Tech achieved a remarkable 57% revenue growth in 2023, reflecting strong performance in the global beauty and wellness market, although its stock price has been volatile, the company's fundamentals remain robust.
- Improved Profitability: The company's operating margin increased from 8.5% to 14.6%, with net income nearly tripling to $58.5 million, indicating enhanced profitability that is likely to attract more investor interest in the future.
- Adjusted Market Expectations: Despite Oddity's stock performing modestly in 2023, the company has a positive outlook for 2025, expecting net revenue to exceed $800 million with a growth rate between 24% and 25%, showcasing its long-term growth potential.
- Strong Cash Flow: Oddity generated $90 million in free cash flow in the first nine months of 2025, indicating that its business is generating capital to support further expansion, which enhances market confidence in its future development.
See More
Evercore ISI Sees Strong Outlook for Oddity Tech
- Investment Recommendation: Evercore ISI has added Oddity Tech Ltd. (ODD) to its list of best SMID Core Idea stock picks for 2026, citing the company's strong fundamentals and high-retention subscription model that demonstrates consistent cash generation capabilities.
- Revenue Growth Potential: Analyst Mark Mahaney highlighted that approximately two-thirds of Oddity Tech's revenue comes from repeat customers, indicating a defensive growth profile, with core brands expected to continue delivering double-digit growth, supporting future revenue increases.
- Attractive Valuation: Oddity Tech currently trades at 7X EV/EBITDA and 15X P/E, which is considered attractive relative to peers, potentially drawing more investor interest.
- Market Performance: Despite Oddity Tech's shares being down 18.0% year-to-date, the strong brand momentum and an upcoming major product cycle provide a favorable risk-reward outlook for investors.
See More
Oversold Consumer Staples Stocks Present Investment Opportunities: ODD, ELAB, ZVIA
- Oversold Stock Overview: In the consumer staples sector, ODDITY Tech, PMGC Holdings, and Zevia have relative strength indices (RSI) below 30, at 25.3, 16.2, and 26 respectively, indicating these stocks are significantly undervalued and may present buying opportunities for investors.
- ODDITY Tech Rating Adjustment: Keybanc analyst maintained an Overweight rating on ODDITY Tech but lowered the price target from $70 to $50, reflecting market caution regarding its future performance, despite its stock price falling approximately 20% over the past month.
- PMGC Holdings Reverse Split: PMGC Holdings announced a 1-for-4 reverse split and invested in non-controlling shares of Nuclea Energy; however, its stock plummeted 73% over the past month, currently at a 52-week low of $3.54 with an RSI of 16.2.
- Zevia Stock Performance: Telsey Advisory Group analyst maintained an Outperform rating for Zevia with a price target of $6, even as its stock fell 33% over the past month to a 52-week low of $1.66, with an RSI of 26 indicating potential for a rebound.
See More
Mid-to-Low Cap Consumer Staples Stocks Earn A+ EPS Revision Ratings
- Analyst Rating Upgrades: As earnings season begins, low-to-mid cap consumer staples stocks like The Andersons (ANDE) and Beyond Meat (BYND) have received an A+ EPS revision rating from analysts, indicating growing confidence in their profitability outlook.
- Improved Earnings Expectations: Companies such as Freshpet (FRPT) and John B. Sanfilippo & Son (JBSS) have shown strong performance in recent earnings estimate upgrades, suggesting an improvement in their fundamentals.
- Increased Market Attention: Firms like Oddity Tech (ODD) and Reynolds Consumer Products (REYN) are attracting investor interest due to their strong earnings momentum, with positive analyst revisions likely to drive stock price increases.
- Industry Trend Analysis: Companies such as Turning Point Brands (TPB) and Village Farms International (VFF) are performing well in the current market environment, demonstrating resilience in the consumer staples sector amid structural challenges.
See More
Oddity Tech Launches Methodiq Platform, Expected to Attract Tens of Millions of Users
- Data-Driven Growth: Oddity Tech has enhanced customer loyalty through its direct-to-consumer platform by leveraging data analytics, resulting in higher repeat purchase rates and increased shareholder value.
- Launch of Methodiq Platform: In November 2025, Oddity launched the Methodiq telehealth platform aimed at providing personalized treatment solutions for tens of millions of Americans suffering from skin conditions, which is expected to significantly enhance the company's long-term growth potential.
- Product Diversification: Methodiq will offer over 100 personalized treatment plans utilizing AI-powered skin analysis and computer vision technology, catering to diverse user needs and further expanding market share.
- Strategic Investment Outlook: With the launch of Methodiq, Oddity Tech is poised to attract more consumers willing to pay premium prices for beauty products, unlocking substantial growth opportunities and driving future shareholder returns.
See More
Oddity Launches Methodiq Platform, Expanding into Dermatological Health Market
- Market Potential: Oddity's addressable market is vast, as the beauty and wellness industry largely operates on an old-economy model, while Oddity's tech-driven e-commerce approach shows strong growth potential.
- Customer Loyalty Boost: By leveraging user data, Oddity has rapidly increased customer loyalty with impressive repeat purchase rates, thereby enhancing the company's competitive edge and shareholder value.
- New Platform Launch: In November 2025, Oddity launched the Methodiq telehealth platform aimed at providing effective treatments for dermatological issues to tens of millions of Americans, which is expected to significantly enhance the company's long-term growth potential.
- Product Diversification: Methodiq will offer over 100 personalized treatment plans utilizing AI technology and proprietary ingredients from Oddity Labs, catering to diverse user needs and further expanding Oddity's market share.
See More
Oddity Tech Reports 57% Revenue Growth Post-IPO and Margin Expansion
- Significant Revenue Growth: Oddity Tech achieved a remarkable 57% revenue growth in 2023, reflecting strong performance in the global beauty and wellness market, although its stock price has been volatile, the company's fundamentals remain robust.
- Improved Profitability: The company's operating margin increased from 8.5% to 14.6%, with net income nearly tripling to $58.5 million, indicating enhanced profitability that is likely to attract more investor interest in the future.
- Adjusted Market Expectations: Despite Oddity's stock performing modestly in 2023, the company has a positive outlook for 2025, expecting net revenue to exceed $800 million with a growth rate between 24% and 25%, showcasing its long-term growth potential.
- Strong Cash Flow: Oddity generated $90 million in free cash flow in the first nine months of 2025, indicating that its business is generating capital to support further expansion, which enhances market confidence in its future development.
See More
